142 related articles for article (PubMed ID: 2109183)
1. 2'-Fluoro-2',3'-dideoxyarabinosyladenine: a metabolically stable analogue of the antiretroviral agent 2',3'-dideoxyadenosine.
Masood R; Ahluwalia GS; Cooney DA; Fridland A; Marquez VE; Driscoll JS; Hao Z; Mitsuya H; Perno CF; Broder S
Mol Pharmacol; 1990 Apr; 37(4):590-6. PubMed ID: 2109183
[TBL] [Abstract][Full Text] [Related]
2. Enhancement by 2'-deoxycoformycin of the 5'-phosphorylation and anti-human immunodeficiency virus activity of 2',3'-dideoxyadenosine and 2'-beta-fluoro-2',3'-dideoxyadenosine.
Ahluwalia GS; Cooney DA; Shirasaka T; Mitsuya H; Driscoll JS; Johns DG
Mol Pharmacol; 1994 Nov; 46(5):1002-8. PubMed ID: 7969062
[TBL] [Abstract][Full Text] [Related]
3. cycloSal-Pronucleotides of 2'-fluoro-ara- and 2'-fluoro-ribo-2',3'- dideoxyadenosine as a strategy to bypass a metabolic blockade.
Meier C; Knispel T; Marquez VE; Siddiqui MA; De Clercq E; Balzarini J
J Med Chem; 1999 May; 42(9):1615-24. PubMed ID: 10229630
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo evaluation of 6-azido-2',3'-dideoxy-2'-fluoro-beta-D-arabinofuranosylpurine and N6-methyl-2',3'-dideoxy-2'-fluoro-beta-D-arabinofuranosyladenine as prodrugs of the anti-HIV nucleosides 2'-F-ara-ddA and 2'-F-ara-ddI.
Koudriakova T; Manouilov KK; Shanmuganathan K; Kotra LP; Boudinot FD; Cretton-Scott E; Sommadossi JP; Schinazi RF; Chu CK
J Med Chem; 1996 Nov; 39(23):4676-81. PubMed ID: 8917656
[TBL] [Abstract][Full Text] [Related]
5. Role of altered metabolism in dideoxynucleoside pharmacokinetics. Studies of 2'-beta-fluoro-2',3'-dideoxyinosine and 2'-beta-fluoro-2',3'-dideoxyadenosine in rats.
Singhal D; Morgan ME; Anderson BD
Drug Metab Dispos; 1996 Oct; 24(10):1155-61. PubMed ID: 8894519
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the anti-human immunodeficiency virus nucleosides 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine.
Hartman NR; Ahluwalia GS; Cooney DA; Mitsuya H; Kageyama S; Fridland A; Broder S; Johns DG
Mol Pharmacol; 1991 Jul; 40(1):118-24. PubMed ID: 1677450
[TBL] [Abstract][Full Text] [Related]
7. Metabolic pathways for the activation of the antiretroviral agent 2',3'-dideoxyadenosine in human lymphoid cells.
Johnson MA; Ahluwalia G; Connelly MC; Cooney DA; Broder S; Johns DG; Fridland A
J Biol Chem; 1988 Oct; 263(30):15354-7. PubMed ID: 3262616
[TBL] [Abstract][Full Text] [Related]
8. Metabolic basis of arabinonucleoside selectivity for human leukemic T- and B-lymphoblasts.
Verhoef V; Fridland A
Cancer Res; 1985 Aug; 45(8):3646-50. PubMed ID: 2410098
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of the anti-HIV-1 activity of ddAdo by coformycin, EHNA and deaza-EHNA derivatives.
Marongiu ME; Pani A; Tinti E; Grifantini M; Franchetti P; Cristalli G; La Colla P
New Microbiol; 1995 Oct; 18(4):359-70. PubMed ID: 8590388
[TBL] [Abstract][Full Text] [Related]
10. cycloSal-Pronucleotides of 2',3'-dideoxyadenosine and 2', 3'-dideoxy-2',3'-didehydroadenosine: synthesis and antiviral evaluation of a highly efficient nucleotide delivery system.
Meier C; Knispel T; De Clercq E; Balzarini J
J Med Chem; 1999 May; 42(9):1604-14. PubMed ID: 10229629
[TBL] [Abstract][Full Text] [Related]
11. Substrate specificity of human deoxycytidine kinase toward antiviral 2',3'-dideoxynucleoside analogs.
Kierdaszuk B; Bohman C; Ullman B; Eriksson S
Biochem Pharmacol; 1992 Jan; 43(2):197-206. PubMed ID: 1739408
[TBL] [Abstract][Full Text] [Related]
12. Enhanced stimulation by ribavirin of the 5'-phosphorylation and anti-human immunodeficiency virus activity of purine 2'-beta-fluoro-2',3'-dideoxynucleosides.
Johns DG; Ahluwalia GS; Cooney DA; Mitsuya H; Driscoll JS
Mol Pharmacol; 1993 Sep; 44(3):519-23. PubMed ID: 8371712
[TBL] [Abstract][Full Text] [Related]
13. Permeation and salvage of dideoxyadenosine in mammalian cells.
Plagemann PG; Woffendin C
Mol Pharmacol; 1989 Jul; 36(1):185-92. PubMed ID: 2787472
[TBL] [Abstract][Full Text] [Related]
14. Enzymatic properties of the unnatural beta-L-enantiomers of 2',3'-dideoxyadenosine and 2',3'-didehydro-2',3'-dideoxyadenosine.
Pélicano H; Pierra C; Eriksson S; Gosselin G; Imbach JL; Maury G
J Med Chem; 1997 Nov; 40(24):3969-73. PubMed ID: 9397178
[TBL] [Abstract][Full Text] [Related]
15. Role of brain tissue localized purine metabolizing enzymes in the central nervous system delivery of anti-HIV agents 2'-beta-fluoro-2',3'-dideoxyinosine and 2'-beta-fluoro-2',3'-dideoxyadenosine in rats.
Singhal D; Morgan ME; Anderson BD
Pharm Res; 1997 Jun; 14(6):786-92. PubMed ID: 9210198
[TBL] [Abstract][Full Text] [Related]
16. Proposed mechanism of therapeutic selectivity for 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia based upon lower capacities for transport and phosphorylation in proliferative intestinal epithelium compared to tumor cells.
Barrueco JR; Jacobsen DM; Chang CH; Brockman RW; Sirotnak FM
Cancer Res; 1987 Feb; 47(3):700-6. PubMed ID: 3802076
[TBL] [Abstract][Full Text] [Related]
17. Biochemical genetic analysis of 2',3'-dideoxyadenosine metabolism in human T lymphocytes.
Carson DA; Haertle T; Wasson DB; Richman DD
Biochem Biophys Res Commun; 1988 Mar; 151(2):788-93. PubMed ID: 3258154
[TBL] [Abstract][Full Text] [Related]
18. Two approaches that increase the activity of analogs of adenine nucleosides in animal cells.
Plunkett W; Cohen SS
Cancer Res; 1975 Jun; 35(6):1547-54. PubMed ID: 1079475
[TBL] [Abstract][Full Text] [Related]
19. Identification of the mechanism of activation of 9-beta-D-arabinofuranosyladenine in human lymphoid cells using mutants deficient in nucleoside kinases.
Verhoef V; Sarup J; Fridland A
Cancer Res; 1981 Nov; 41(11 Pt 1):4478-83. PubMed ID: 6272978
[TBL] [Abstract][Full Text] [Related]
20. Metabolism and chemotherapeutic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia L1210 and evidence for its phosphorylation by deoxycytidine kinase.
Brockman RW; Cheng YC; Schabel FM; Montgomery JA
Cancer Res; 1980 Oct; 40(10):3610-5. PubMed ID: 6254636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
